Trade Alphatec Holdings Inc - ATEC CFD

Alphatecs Company profile

About Alphatec Holdings Inc

Alphatec Holdings, Inc. is a medical technology company. The Company is focused on the design, development, and advancement of technology for surgical treatment of spinal disorders. The Company, through its wholly owned subsidiaries, Alphatec Spine, Inc., SafeOp Surgical, Inc. and EOS imaging S.A. is focused on developing approaches that integrate with its Alpha InformatiX product platform. It has a range of product portfolios designed to address the spine’s various pathologies. Its product portfolio includes Alpha InformatiX, which include SafeOp Neural InformatiX System; Access Systems, which include Sigma-TLIF Pedicle-based Access System, PTP Patient Positioning System, and Squadron Lateral Retractor; Fixation Systems, which include InVictus Spinal Fixation Systems (Open and MIS), InVictus MIS SingleStep System, and InVictus Modular Fixation Systems (Open and MIS) and Interbody Systems, which include IdentiTi Porous Ti Interbody Implants and Transcend Lateral Interbody Implants.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Alphatec Holdings Inc revenues increased 68% to $243.2M. Net loss increased 83% to $144.3M. Revenues reflect Revenue from products and services increase of 72% to $242.3M. Higher net loss reflects Selling/General/Admin Expense increase of 73% to $197.6M (expense), Stock-based compensation-SGA increase from $15M to $31.7M (expense), Research and development - Balancing increase of 68% to $28M (expense).

Equity composition

Common Stock $.0001 Par, 04/11, 200M auth., 89,059,000 issd. less treasury shares 19 issued @ 97K. Insiders owns 3.77%. IPO: 6/2/06, 9.3M shares @$9 by Deutsche Bank Securities Inc., First Albany Capital Inc., RBC Capital Markets Corporation and Joseph Gunner & Co., LLC.